These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15451145)

  • 1. Inflammation and restenosis after percutaneous coronary interventions.
    Toutouzas K; Colombo A; Stefanadis C
    Eur Heart J; 2004 Oct; 25(19):1679-87. PubMed ID: 15451145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
    Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
    Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
    Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
    J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is inflammation a contributor for coronary stent restenosis?
    Li JJ; Nie SP; Zhang CY; Gao Z; Zheng X; Guo YL
    Med Hypotheses; 2007; 68(5):945-51. PubMed ID: 17045418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiotensin receptor 1 blockers in restenosis prevention after percutaneous coronary interventions.
    Vassilev D; Doganov A; Gil RJ
    Kardiol Pol; 2010 Jan; 68(1):97-101. PubMed ID: 20131196
    [No Abstract]   [Full Text] [Related]  

  • 8. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening.
    Inoue T; Kato T; Hikichi Y; Hashimoto S; Hirase T; Morooka T; Imoto Y; Takeda Y; Sendo F; Node K
    Thromb Haemost; 2006 Jan; 95(1):43-8. PubMed ID: 16543960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.
    Aronson D
    Int J Cardiovasc Intervent; 2004; 6(3-4):110-8. PubMed ID: 16146903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy.
    Agema WR; Jukema JW; Pimstone SN; Kastelein JJ
    Eur Heart J; 2001 Nov; 22(22):2058-74. PubMed ID: 11686664
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoconstriction and coronary artery spasm after drug-eluting stent placement.
    Togni M; Eberli FR
    J Invasive Cardiol; 2006 Dec; 18(12):593. PubMed ID: 17197708
    [No Abstract]   [Full Text] [Related]  

  • 13. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory response after coronary angioplasty - mechanisms and significance].
    Koziński M; Kubica J
    Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is homocysteine a new factor in the pathogenesis of restenosis after percutaneous coronary angioplasty?].
    Jankowski P; Bryniarski L; Styczkiewicz K; Bilo G; Curyło A; Kawecka-Jaszcz K
    Przegl Lek; 2003; 60(8):527-31. PubMed ID: 14974346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque sealing by coronary angioplasty.
    Meier B
    Heart; 2004 Dec; 90(12):1395-8. PubMed ID: 15547010
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathophysiology and burden of restenosis.
    Weintraub WS
    Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.